Changes between Initial Version and Version 1 of 2016-01-21


Ignore:
Timestamp:
Jan 21, 2016, 3:23:57 PM (10 years ago)
Author:
Conrad Huang
Comment:

--

Legend:

Unmodified
Added
Removed
Modified
  • 2016-01-21

    v1 v1  
     1= Attendees =
     2
     3  Elaine, Eric, Greg, TomF, TomG, Conrad
     4
     5= Agenda =
     6  * Review action items from last meeting
     7  * Distribution package on Mac
     8  * Symmetry web service
     9  * Nucleotides
     10
     11= Discussion =
     12  * ChimeraX.pkg almost ready for prime time
     13    * Fix relocation option
     14    * Add welcome, license and icon
     15    * Update web site link when ready (ask Elaine)
     16  * Web service implementing Peter Rose paper on symmetry
     17    * Read paper
     18    * Get API
     19    * Decide how to present information (command, tool, something else?)
     20  * Nucleotides
     21    * Work with Andreas to determine what types of representations are desirable
     22    * Add and use cross section for nucleic acid residues
     23= Outstanding Action Items =
     24  * Fix semicolon processing on command line (Greg)
     25  * Test wx AUI on Windows (Greg)
     26  * Friends and Family bugs outstanding
     27   * New version of phoenix (Greg)
     28    * Make Linux release if new version works well (Greg)
     29   * Ribbon strand smoothing (Conrad)
     30   * Stretch goals
     31    * Hither/Yon planes in side view (Greg)
     32    * Save global pseudobond manager in sessions (Eric)
     33    * Finish mmCIF NMR structure support (Greg)
     34    * Figure out and fix Mac OS X runtime linking bug (TomG/Greg/Conrad)
     35    * First-time start-up failure after installation from dmg (TomG/Greg/Conrad/Eric)
     36    * Save molecular surfaces in sessions (Eric/TomG)
     37  * Announcing ChimeraX release
     38   * Need licensing agreement
     39   * Invite the follow to try current version:
     40     * Oliver Clarke (TomF)
     41     * Jane Richardson (defer until ribbons look just plain beautiful)
     42   * Should we focus on specific people/groups or cast a broad net?